Intestinal Absorption of a β-Adrenergic Blocking Agent Nadolol. II. : Mechanism of the Inhibitory Effect on the Intestinal Absorption of Nadolol by Sodium Cholate in Rats
スポンサーリンク
概要
- 論文の詳細を見る
The mechanism of the inhibitory effect of sodium cholate and its taurine and glycine conjugates on the intestinal absorption of nadolol was investigated in rats. It was found that the uptake of nadolol into the intestinal membrane was inhibited by sodium cholate and its conjugates, but the membrane permeability to nadolol was not affected. The inhibitory effect on nadolol absorption can be interpreted in terms of loss of thermodynamic activity of nadolol due to stable micelle formation, resulting in a decrease of the uptake into the intestinal membrane. Other β-blocking agents also form micellar complexes with sodium cholate, but their micelles are ten times less stable than that of nadolol. It is concluded that the stability of the micellar complex may be an important factor in the inhibition of intestinal absorption of nadolol. The micellar stability seems to be associated with not only the chemical nature of the bile salts but also that of the drug.
- 公益社団法人日本薬学会の論文
- 1986-09-25
著者
-
山口 俊和
Department Of Drug Metabolism Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
池田 知左登
Department of Drug Metabolism, Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
関根 豊
Department of Drug Metabolism, Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
関根 豊
Department Of Drug Metabolism Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
池田 知左登
Department Of Drug Metabolism Research Laboratories Dainippon Pharmaceutical Co. Ltd.
関連論文
- マウスおよびラットにおけるLoperamide Hydrochlorideの身体依存性
- Studies on the Metabolism of Sulfadiazine. I. On the Separation and Identification of Excrements in Human Urine after its Oral Administration.
- Metabolism of Piromidic Acid, a New Antibacterial Agent. V. Pharmacokinetics of Piromidic Acid in Humans
- Metabolism of Piromidic Acid, a New Antibacterial Agent. IV. Pharmacokinetics of Piromidic Acid in Rats
- Metabolism of Piromidic Acid, a New Antibacterial Agent. III. Determination of Piromidic Acid and Its Metabolites in Blood, Urine and Bile of Rats and Humans
- Metabolism of Piromidic Acid, a New Antibacterial Agent. II. In Vitro Metabolic Pathway of Piromidic Acid in Rats
- Intestinal Absorption of a β-Adrenergic Blocking Agent Nadolol. III. : Nuclear Magnetic Resonance Spectroscopic Study on Nadolol-Sodium Cholate Micellar Complex and Intestinal Absorption of Nadolol Derivatives in Rats
- Intestinal Absorption of a β-Adrenergic Blocking Agent Nadolol. II. : Mechanism of the Inhibitory Effect on the Intestinal Absorption of Nadolol by Sodium Cholate in Rats
- Intestinal Absorption of β-Adrenergic Blocking Agent Nadolol. I. : Comparison of Absorption Behaivor of Nadolol with Those of Other β-Blocking Agents in Rats
- Studies on the Metabolism of Sulfadiazine. II. Quantitative Separation of Excrements in the Human Urine after Administration of Sulfadiazine